Open AccessA phase 1b/pharmacokinetic trial of PTC299, a novel post-transcriptional VEGF inhibitor, for AIDS-related Kaposi’s sarcoma: AIDS Malignancy Consortium trial 059
Author(s) -
Rachel A. Bender Ignacio,
Jeannette Lee,
Michelle A. Rudek,
Dirk P. Dittmer,
Richard F. Ambinder,
Susan E. Krown,
David M. Aboulafia,
Robert A. Baiocchi,
Elizabeth Y. Chiao,
Bruce J. Dezube,
Ronald T. Mitsuyasu,
Erin Reid,
Bruce Shiramizu,
Joseph A. Sparano,
Anil Tulpule,
Anthony Eason,
Veenadhari Chavakula,
Julia Lynne
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/q862-w217
Subject(s) - malignancy , sarcoma , vegf receptors , human immunodeficiency virus (hiv) , medicine , oncology , pharmacokinetics , clinical trial , virology , pathology